Trademark: 87937170
Status Date
Monday, July 4, 2022
Filing Date
Friday, May 25, 2018
Published for Opposition
Tuesday, April 7, 2020
Abandoned Date
Monday, July 4, 2022
5 Reagents for use in veterinary and medical diagnostic tests except tests in the field of immunohematology and transfusion medicine; reagents for use in medical and veterinary research except tests in the field of immunohematology and transfusion medicine; diagnostic reagents for use in medical and veterinary screening except tests in the field of immunohematology and transfusion medicine; diagnostic reagents for medical and veterinary diagnostic purposes for use in assays of biological samples, particularly blood except tests in the field of immunohematology and transfusion medicine; diagnostic reagents for medical and veterinary diagnostic purposes for use in assays of samples, particularly blood except tests in the field of immunohematology and transfusion medicine; diagnostic preparations for medical and veterinary diagnostic purposes for use in relation to food intolerance testing; pharmaceutical substances based on affinity reagents equivalent to antibodies, and products comprising them, all for use in medical and/or veterinary screening except tests in the field of immunohematology and transfusion medicine; pharmaceutical preparations in the nature of antigens for medical diagnostic use and veterinary diagnostic use and/or pharmaceutical purposes for the detection of cancer, inflammatory diseases, food allergies, infections, autoimmune disorders and for immunity testing but not immunohemotology and transfusion medicine; diagnostic and/or pharmaceutical preparations containing antigens except preparations in the field of immunohematology and transfusion medicine, for use in medical and veterinary treatment in the nature of anti-infectives, cancer immunotherapies, anti-inflammatory diseases, and genetic conditions; pharmaceutical preparation in the nature of substrates impregnated with or carrying antigens for medical diagnostic use and veterinary diagnostic use and pharmaceutical purposes other than immunohematology and transfusion medicine for the detection of cancers, inflammatory diseases, food allergies, infections, autoimmune disorders and for immunity testing; affinity reagents, namely, protein binding agents equivalent to antibodies for medical diagnostic use and veterinary diagnostic use and/or pharmaceutical purposes for the detection of cancers, inflammatory diseases, food allergies, infections, autoimmune disorders and for immunity testing but not immunohematology and transfusion medicine; pharmaceutical or diagnostic preparations containing affinity reagents, namely, protein binding agents equivalent to antibodies except in connection with immunohematology or transfusion medicine for medical diagnostic use and veterinary diagnostic use in the nature of anti-infectives, cancer immunotherapies, anti-inflammatory diseases and genetic conditions; pharmaceutical preparations in the nature of substrates impregnated with or carrying affinity reagents, namely, protein binding agents equivalent to antibodies for medical diagnostic use and veterinary diagnostic use in the nature of anti-infectives, cancer immunotherapies, anti-inflammatory diseases and genetic conditions; wound dressings; medical plasters; antiseptic wipes; diagnostic reagents for medical use except in connection with immunohematology and transfusion medicine containing any of the aforesaid products; food intolerance test kits comprising diagnostic test patches for application to the skin for determining allergies; reagents, namely, protein binding agents for use in scientific research; reagents, namely, protein binding agents for use in scientific screening; genetic testing kits comprised of reagents for medical purposes; genetic testing kits comprised of reagents for medical purposes for animals; genetic testing kits comprised of reagents for medical purposes; genetic testing kits comprised of reagents for medical purposes for animals
Jul 5, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 4, 2022
Abandonment - No Use Statement Filed
Dec 4, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 2, 2021
Sou Extension 3 Granted
Dec 2, 2021
Sou Extension 3 Filed
Dec 2, 2021
Sou Teas Extension Received
May 27, 2021
Notice Of Approval Of Extension Request E-Mailed
May 25, 2021
Sou Extension 2 Granted
May 25, 2021
Sou Extension 2 Filed
May 25, 2021
Sou Teas Extension Received
Dec 3, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 1, 2020
Sou Extension 1 Granted
Dec 1, 2020
Sou Extension 1 Filed
Dec 1, 2020
Sou Teas Extension Received
Jun 2, 2020
Noa E-Mailed - Sou Required From Applicant
Apr 7, 2020
Official Gazette Publication Confirmation E-Mailed
Apr 7, 2020
Published For Opposition
Mar 18, 2020
Notification Of Notice Of Publication E-Mailed
Feb 29, 2020
Approved For Pub - Principal Register
Feb 6, 2020
Teas/Email Correspondence Entered
Feb 6, 2020
Correspondence Received In Law Office
Feb 6, 2020
Teas Response To Office Action Received
Aug 6, 2019
Notification Of Non-Final Action E-Mailed
Aug 6, 2019
Non-Final Action E-Mailed
Aug 6, 2019
Non-Final Action Written
Jul 29, 2019
Previous Allowance Count Withdrawn
Jun 18, 2019
Withdrawn From Pub - Og Review Query
Jun 3, 2019
Electronic Record Review Complete
May 31, 2019
On Hold - Electronic Record Review Required
May 23, 2019
Approved For Pub - Principal Register
May 15, 2019
Teas/Email Correspondence Entered
May 15, 2019
Correspondence Received In Law Office
May 15, 2019
Assigned To Lie
May 8, 2019
Teas Response To Suspension Inquiry Received
Apr 10, 2019
Notification Of Letter Of Suspension E-Mailed
Apr 10, 2019
Letter Of Suspension E-Mailed
Apr 10, 2019
Suspension Letter Written
Mar 20, 2019
Teas/Email Correspondence Entered
Mar 20, 2019
Correspondence Received In Law Office
Mar 20, 2019
Teas Response To Office Action Received
Sep 24, 2018
Notification Of Non-Final Action E-Mailed
Sep 24, 2018
Non-Final Action E-Mailed
Sep 24, 2018
Non-Final Action Written
Sep 15, 2018
Assigned To Examiner
Jun 3, 2018
New Application Office Supplied Data Entered
May 29, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
